eCOAs are not new, but despite being recommended by regulatory authorities like the U.S FDA, many study teams still choose to collect assessment data with pen and paper. Find out why paper COAs add unnecessary risk, especially with trials becoming more advanced and the industry acknowledging the need to reach more diverse and widely dispersed populations of patients.

One aspect of study design to consider when building better research experiences for patients is a genuinely patient-centered eCOA program. Here are some tips for ensuring that your eCOA is built with the needs of patients in mind and able to deliver the kind of engagement necessary for successful trials.

It is critical to ensure clinical trials are truly patient-centered. Although the intention to incorporate patient input and feedback can be seen throughout the clinical research industry, clinical research studies often don’t rise to that challenge. Find out how eCOA can improve patient experience in clinical trials.